Stockscreener 앱 받기
36.99
5.37%
-2.10
시장 영업 전:
37.27
0.28
+0.76%
Springworks Therapeutics Inc 주식(SWTX)의 최신 뉴스
Massachusetts Financial Services Co. MA Sells 50,547 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Trading 5.5% HigherHere's Why - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Bought by Schroder Investment Management Group - MarketBeat
Vanguard Group Inc. Has $258.65 Million Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
KLP Kapitalforvaltning AS Buys Shares of 12,600 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
NEOS Investment Management LLC Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Pictet Asset Management Holding SA Has $86.40 Million Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Stock Surge: An Investor’s Dilemma - timothysykes.com
SpringWorks Therapeutics Enters Oversold Territory (SWTX) - Nasdaq
BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Segall Bryant & Hamill LLC Has $6.99 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Cibc World Markets Corp Acquires New Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Swiss National Bank Has $4.22 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat
SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart
Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR
Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
FDA’s new and supplemental approvals in February - BioCentury
Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga
SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat
High Growth Tech Stocks In The US Market March 2025 - Simply Wall St
How To Trade (SWTX) - Stock Traders Daily
SpringWorks Therapeutics Inc (SWTX) Q4 2024 Earnings Report Prev - GuruFocus.com
SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView
SpringWorks Therapeutics, Inc.'s (NASDAQ:SWTX) Shares Climb 26% But Its Business Is Yet to Catch Up - Simply Wall St
Victory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz - Seeking Alpha
Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
0.48%
자본화:
|
볼륨(24시간):